874 related articles for article (PubMed ID: 25572484)
1. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
2. Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention.
Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
J Clin Lipidol; 2014; 8(4):423-32. PubMed ID: 25110224
[TBL] [Abstract][Full Text] [Related]
3. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
Zeng RX; Li XL; Zhang MZ; Guo YL; Zhu CG; Guo LH; Li S; Zhang Y; Li JJ
Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
Zhong Z; Liu J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Med Sci Monit; 2018 Jun; 24():4154-4161. PubMed ID: 29910459
[TBL] [Abstract][Full Text] [Related]
5. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
6. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
Zeng RX; Li S; Zhang MZ; Li XL; Zhu CG; Guo YL; Zhang Y; Li JJ
J Cardiol; 2017 Aug; 70(2):113-120. PubMed ID: 28209463
[TBL] [Abstract][Full Text] [Related]
7. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
[TBL] [Abstract][Full Text] [Related]
8. The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention.
Li XL; Li JJ; Guo YL; Zhu CG; Qing P; Wu NQ; Xu B; Gao RL
Clin Cardiol; 2014 Sep; 37(9):558-65. PubMed ID: 25113039
[TBL] [Abstract][Full Text] [Related]
9. Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention.
Buturak A; Degirmencioglu A; Erturk M; Karakurt H; Demir AR; Surgit O; Pusuroglu H; Akgul O; Serteser M; Norgaz T; Gorgulu S
Coron Artery Dis; 2015 Jun; 26(4):333-40. PubMed ID: 25714068
[TBL] [Abstract][Full Text] [Related]
10. Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention.
Harada K; Kikuchi R; Suzuki S; Tanaka A; Aoki T; Iwakawa N; Kojima H; Hirayama K; Mitsuda T; Sumi T; Negishi Y; Ishii H; Murohara T
Lipids Health Dis; 2018 Feb; 17(1):21. PubMed ID: 29391013
[TBL] [Abstract][Full Text] [Related]
11. Clinical predictors for progression of nonintervened nonculprit coronary lesions despite low-density lipoprotein cholesterol less than 1.8 mmol/l after successful stent implantation.
Yin ZX; Zhou YJ; Liu XL; Han HY; Yang SW
Coron Artery Dis; 2011 Mar; 22(1):49-54. PubMed ID: 21150778
[TBL] [Abstract][Full Text] [Related]
12. Effects of polyunsaturated fatty acids on periprocedural myocardial infarction after elective percutaneous coronary intervention.
Suzuki A; Ando H; Takashima H; Kumagai S; Kurita A; Waseda K; Suzuki Y; Mizuno T; Harada K; Uetani T; Takahashi H; Yoshikawa D; Ishii H; Murohara T; Amano T
EuroIntervention; 2014 Nov; 10(7):792-8. PubMed ID: 25415148
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
[TBL] [Abstract][Full Text] [Related]
14. Relationship of glycated hemoglobin levels with myocardial injury following elective percutaneous coronary intervention in patients with type 2 diabetes mellitus.
Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
PLoS One; 2014; 9(7):e101719. PubMed ID: 24988213
[TBL] [Abstract][Full Text] [Related]
15. Relationship of non-cardiac biomarkers with periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.
Zeng RX; Li JJ; Liao PD; Zhang MZ
Int J Cardiol; 2016 Oct; 221():726-33. PubMed ID: 27428312
[TBL] [Abstract][Full Text] [Related]
16. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.
Tanaka F; Makita S; Onoda T; Tanno K; Ohsawa M; Itai K; Sakata K; Omama S; Yoshida Y; Ogasawara K; Ogawa A; Ishibashi Y; Kuribayashi T; Okayama A; Nakamura M;
Am J Cardiol; 2013 Oct; 112(8):1063-8. PubMed ID: 23831165
[TBL] [Abstract][Full Text] [Related]
18. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
[TBL] [Abstract][Full Text] [Related]
19. Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation.
Wolfram RM; Brewer HB; Xue Z; Satler LF; Pichard AD; Kent KM; Waksman R
Am J Cardiol; 2006 Sep; 98(6):711-7. PubMed ID: 16950168
[TBL] [Abstract][Full Text] [Related]
20. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]